CAMO-Net
Working together to
address AMR
Welcome
We are the Centres for Antimicrobial Optimisation Network, known as CAMO-Net. We are a Wellcome funded, multidisciplinary, global collaboration of well-established research institutions who have an expertise in antimicrobial resistance (AMR).
We are based across 13 sites in 11 countries around the world, predominantly in the global south where people are disproportionately affected by AMR. With local expertise, we are at the forefront of addressing one of the world’s most pressing health crises.
Latest news
- National Hub
- Technical Support and Development Centre
- Shadow National Site
About us
Our research is underpinned by the values of equity, local leadership, co-production of activities, knowledge mobilisation, mutual cross-regional learning, training, capacity and capabilities strengthening, and output sharing.
Our vision
Our vision is a world where the appropriate, evidence-based use of antimicrobials is commonplace, supported by equitable availability and accessibility.
Our mission
CAMO-Net’s mission is to complement and enhance the existing ecosystem of global programmes designed to alleviate the global burden and impact of antimicrobial resistance (AMR) and poorly treated infections by creating and nurturing a sustainable and equitable ecosystem for global research to optimise the use of antimicrobials in humans.
This will be achieved through producing contextually relevant tools, technologies, guidelines, and practices that can be readily implemented with the support of governments and policymakers.
Latest posts
Read more about our paper, published in @LancetDigitalH, which explores how clinicians use AI decision support when prescribing antibiotics under uncertainty.
It's all on our blog 👇
New research from CAMO-Net Uganda 🇺🇬 in @SpringerNature estimates that antibiotic resistance cost Uganda US$1.43 million in 2024.
Women are disproportionately affected, underlining the need for gender-responsive stewardship policies.
Read more 👉 https://camonet.org/2025/12/15/new-research-reveals-the-societal-economic-burden-of-antibiotic-resistance-in-uganda/
Our latest paper, from CAMO-Net UK, highlights the importance of trust, usability and evidence when using AI-driven decision support. #AMR #AIinHealthcare
NEW Research: The impact of artificial intelligence-driven decision support on uncertain antimicrobial prescribing: a randomised, multimethod study. @TmRawson @MGilchrist123 @pgeorgiou_ic @CAMO_Net1 @FlemingCentre @imperialcollege
Read it here: https://buff.ly/GLvRRkU
Some of our researchers are together in Chandigarh for a hands-on workshop on dose optimisation and Pop-PK studies at PGIMER hospital. Learning, collaborating, and sharing skills with incredible Indian facilitators
3
